Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics by rss feed | Mar 3, 2026 | News Feeds Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). Read Original Copy